ALK and neoplasm: In addition, heterogeneity in relation to MYCN amplification and actionable ALK genetic alterations were detected in cfDNA samples for which such alterations were not detectable in their matched tumour tissue counterparts, suggesting the promising potential of liquid biopsies in capturing the heterogeneity of the tumour and relapsed samples [42].